NCT07230405 2026-02-06
A Phase II Study of SKB571 in Patients With Lung Cancer
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Phase 2 Recruiting
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Klus Pharma Inc.
BeBetter Med Inc
Universitair Ziekenhuis Brussel
Sun Yat-sen University